IRCT20200412047042N1尚未招募3 期
Evaluation the effect of raltegravir, and raltegravir/interferon beta combination on covid 19 patients admitted in Peymanieh hospital of Jahrom in 2020
Jahrom University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •confirmed diagnosis of COVID19 with RT-PCR hospitalized patients
排除标准
- •Patients with severe dyspnea require mechanical ventilation or hospitalization in intensive care units
- •and patients with treatment-resistant hypoxemia or those with severe underlying disease
- •Pregnancy or breastfeeding
- •Drug allergy
- •Patient dissatisfaction
研究者
相似试验
进行中（未招募）
不适用
Pharmacokinetic and safety study of RAltegravir and atazanavir in a once DAily dose regimen in HIV-1 in-fected patients (PRADA) - PRADAHIV infected patientsMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2008-008556-16-NLRadboud University Nijmegen Medical Centre
Unknown
不适用
Pilot Study of Raltegravir Lipodystrophy IISPHIV InfectionNCT01164605Southern California Institute for Research and Education30
已完成
2 期
Pharmacokinetic and safety pilotstudy of RAltegravir and atazanavir in a once DAily dose regimen in HIV-1 in-fected patients (PRADA)HIVhuman immunodeficiency virus10047438NL-OMON33412niversitair Medisch Centrum Sint Radboud15
进行中（未招募）
不适用
Pharmacokinetic and safety pilotstudy of RAltegravir and atazanavir in a once DAily dose regimen in HIV-1 in-fected patients (PRADA) - PRADAHIV infected patientsMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2008-008556-16-DERadboud University Nijmegen Medical Centre20
已完成
4 期
Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive PatientsHIV InfectionsNCT00677300Dallas VA Medical Center85